Phoenix-Micron announces MICRON 810nm Image-Guided Laser to advance research into diseases like dry AMD. Preclinical research using rodent models is essential for advancing our understanding of dry age-related macular degeneration (AMD), a leading cause of vision loss with no approved cure. Today we are pleased to announce the immediate availability of two 810nm lasers. Working
19.06
2019
Developing a unique, novel dry AMD model with the Phoenix MICRON® laser injector
The most common cause of blindness in developed societies, age-related macular degeneration (AMD) robs the victim of the crucially important focused macular vision. While still devastating, wet AMD has a robust mouse model and the treatment option of anti-vascular endothelial growth factor (VEGF) subretinal injections. The Phoenix MICRON® laser allows precise delivery of 532 nm